Oragenics Inc (OGEN)
:OGEN
Total Valuation
Oragenics has a market cap or net worth of $2.30M. The enterprise value is $225.25M.
Market Cap$2.30M
Enterprise Value$225.25M
Share Statistics
Oragenics has 4,336,029 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding4,336,029
Owned by Insiders3.50%
Owned by Institutions4.02%
Financial Efficiency
Oragenics’s return on equity (ROE) is -1.19 and return on invested capital (ROIC) is -3.92%.
Return on Equity (ROE)-1.19
Return on Assets (ROA)-0.98
Return on Invested Capital (ROIC)-3.92%
Return on Capital Employed (ROCE)-1.13
Revenue Per Employee0.00
Profits Per Employee-3.28B
Employee Count3
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Oragenics is ―. Oragenics’s PEG ratio is -0.00093.
PE Ratio―
PS Ratio0.00
PB Ratio0.20
Price to Fair Value0.20
Price to FCF>-0.01
Price to Operating Cash Flow-0.24
PEG Ratio-0.00093
Income Statement
In the last 12 months, Oragenics had revenue of 0.00 and earned -9.84M in profits. Earnings per share was -4.56.
Revenue0.00
Gross Profit0.00
Operating Income-9.36M
Pretax Income-9.98M
Net Income-9.84M
EBITDA-9.36M
Earnings Per Share (EPS)-4.56
Cash Flow
In the last 12 months, operating cash flow was -9.25M and capital expenditures -5.00, giving a free cash flow of -9.25M billion.
Operating Cash Flow-9.25M
Free Cash Flow-9.25M
Free Cash Flow per Share-2.13
Dividends & Yields
Oragenics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.18
52-Week Price Change-91.59%
50-Day Moving Average0.79
200-Day Moving Average1.25
Relative Strength Index (RSI)29.32
Average Volume (3m)211.78K
Important Dates
Oragenics upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Oragenics as a current ratio of 5.64, with Debt / Equity ratio of 2745.28%
Current Ratio5.64
Quick Ratio5.64
Debt to Market Cap134.57
Net Debt to EBITDA-23.81
Interest Coverage Ratio-11.91
Taxes
In the past 12 months, Oragenics has paid -136.91K in taxes.
Income Tax-136.91K
Effective Tax Rate0.01
Enterprise Valuation
Oragenics EV to EBITDA ratio is -23.99, with an EV/FCF ratio of -0.02.
EV to Sales0.00
EV to EBITDA-23.99
EV to Free Cash Flow-0.02
EV to Operating Cash Flow-0.02
Balance Sheet
Oragenics has $8.40M in cash and marketable securities with $227.35M in debt, giving a net cash position of -$218.95M billion.
Cash & Marketable Securities$8.40M
Total Debt$227.35M
Net Cash-$218.95M
Net Cash Per Share-$50.50
Tangible Book Value Per Share$3.84
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Oragenics is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast90.27%